65 related articles for article (PubMed ID: 26707502)
1. Downregulation of connective tissue growth factor reduces migration and invasiveness of osteosarcoma cells.
Huang Y; Zhao S; Zhang C; Li X
Mol Med Rep; 2016 Feb; 13(2):1888-94. PubMed ID: 26707502
[TBL] [Abstract][Full Text] [Related]
2. CYR61 downregulation reduces osteosarcoma cell invasion, migration, and metastasis.
Fromigue O; Hamidouche Z; Vaudin P; Lecanda F; Patino A; Barbry P; Mari B; Marie PJ
J Bone Miner Res; 2011 Jul; 26(7):1533-42. PubMed ID: 21312266
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-26b inhibits metastasis of osteosarcoma via targeting CTGF and Smad1.
Duan G; Ren C; Zhang Y; Feng S
Tumour Biol; 2015 Aug; 36(8):6201-9. PubMed ID: 25761878
[TBL] [Abstract][Full Text] [Related]
4. MiR-221 increases osteosarcoma cell proliferation, invasion and migration partly through the downregulation of PTEN.
Zhu J; Liu F; Wu Q; Liu X
Int J Mol Med; 2015 Nov; 36(5):1377-83. PubMed ID: 26397386
[TBL] [Abstract][Full Text] [Related]
5. Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling.
Yang MH; Lin BR; Chang CH; Chen ST; Lin SK; Kuo MY; Jeng YM; Kuo ML; Chang CC
Oncogene; 2012 May; 31(19):2401-11. PubMed ID: 21927029
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of connective tissue growth factor overexpression decreases growth of hepatocellular carcinoma cells in vitro and in vivo.
Jia XQ; Cheng HQ; Li H; Zhu Y; Li YH; Feng ZQ; Zhang JP
Chin Med J (Engl); 2011 Nov; 124(22):3794-9. PubMed ID: 22340243
[TBL] [Abstract][Full Text] [Related]
7. Mutant p53 gain of function can be at the root of dedifferentiation of human osteosarcoma MG63 cells into 3AB-OS cancer stem cells.
Di Fiore R; Marcatti M; Drago-Ferrante R; D'Anneo A; Giuliano M; Carlisi D; De Blasio A; Querques F; Pastore L; Tesoriere G; Vento R
Bone; 2014 Mar; 60():198-212. PubMed ID: 24373920
[TBL] [Abstract][Full Text] [Related]
8. Cyr61 silencing reduces vascularization and dissemination of osteosarcoma tumors.
Habel N; Vilalta M; Bawa O; Opolon P; Blanco J; Fromigué O
Oncogene; 2015 Jun; 34(24):3207-13. PubMed ID: 25065593
[TBL] [Abstract][Full Text] [Related]
9. Functional and biological analysis of Bcl-xL expression in human osteosarcoma.
Wang ZX; Yang JS; Pan X; Wang JR; Li J; Yin YM; De W
Bone; 2010 Aug; 47(2):445-54. PubMed ID: 20580954
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of TNFAIP1 inhibits growth and induces apoptosis in osteosarcoma cells through inhibition of the nuclear factor-κB pathway.
Zhang CL; Wang C; Yan WJ; Gao R; Li YH; Zhou XH
Oncol Rep; 2014 Sep; 32(3):1149-55. PubMed ID: 24969828
[TBL] [Abstract][Full Text] [Related]
11. Silencing of galectin-3 represses osteosarcoma cell migration and invasion through inhibition of FAK/Src/Lyn activation and β-catenin expression and increases susceptibility to chemotherapeutic agents.
Park GB; Kim DJ; Kim YS; Lee HK; Kim CW; Hur DY
Int J Oncol; 2015 Jan; 46(1):185-94. PubMed ID: 25339127
[TBL] [Abstract][Full Text] [Related]
12. CTGF increases drug resistance to paclitaxel by upregulating survivin expression in human osteosarcoma cells.
Tsai HC; Huang CY; Su HL; Tang CH
Biochim Biophys Acta; 2014 May; 1843(5):846-54. PubMed ID: 24462773
[TBL] [Abstract][Full Text] [Related]
13. ErbB3 silencing reduces osteosarcoma cell proliferation and tumor growth in vivo.
Jullien N; Dieudonné FX; Habel N; Marty C; Modrowski D; Patino A; Lecanda F; Sévère N; Marie PJ
Gene; 2013 May; 521(1):55-61. PubMed ID: 23541807
[TBL] [Abstract][Full Text] [Related]
14. RNA interference-mediated knockdown of Livin suppresses cell proliferation and invasion and enhances the chemosensitivity to cisplatin in human osteosarcoma cells.
Li X; Fan S; Li L; Wang L; Fan G; Zhao Q; Li Y
Int J Oncol; 2013 Jul; 43(1):159-68. PubMed ID: 23632777
[TBL] [Abstract][Full Text] [Related]
15. Propofol inhibits proliferation and invasion of osteosarcoma cells by regulation of microRNA-143 expression.
Ye Z; Jingzhong L; Yangbo L; Lei C; Jiandong Y
Oncol Res; 2013; 21(4):201-7. PubMed ID: 24762226
[TBL] [Abstract][Full Text] [Related]
16. CTGF promotes osteosarcoma angiogenesis by regulating miR-543/angiopoietin 2 signaling.
Wang LH; Tsai HC; Cheng YC; Lin CY; Huang YL; Tsai CH; Xu GH; Wang SW; Fong YC; Tang CH
Cancer Lett; 2017 Apr; 391():28-37. PubMed ID: 28108312
[TBL] [Abstract][Full Text] [Related]
17. Role of microRNA‑503 in the suppression of osteosarcoma cell proliferation and migration via modulation of fibroblast growth factor 2.
Wu B; Bi W
Mol Med Rep; 2015 Nov; 12(5):7433-8. PubMed ID: 26461038
[TBL] [Abstract][Full Text] [Related]
18. SOX18 knockdown suppresses the proliferation and metastasis, and induces the apoptosis of osteosarcoma cells.
Wu Z; Liu J; Wang J; Zhang F
Mol Med Rep; 2016 Jan; 13(1):497-504. PubMed ID: 26573263
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol abrogates the effects of hypoxia on cell proliferation, invasion and EMT in osteosarcoma cells through downregulation of the HIF-1α protein.
Sun Y; Wang H; Liu M; Lin F; Hua J
Mol Med Rep; 2015 Mar; 11(3):1975-81. PubMed ID: 25384583
[TBL] [Abstract][Full Text] [Related]
20. Deregulated expression of connective tissue growth factor (CTGF/CCN2) is linked to poor outcome in human cancer.
Wells JE; Howlett M; Cole CH; Kees UR
Int J Cancer; 2015 Aug; 137(3):504-11. PubMed ID: 24832082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
